Blasi, M., Eichhorn, M. E., Christopoulos, P., Winter, H., Heußel, C. P., Herth, F., . . . Kuon, J. (2022). Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: A propensity score-matched analysis. BMC pulmonary medicine, 22, . https://doi.org/10.1186/s12890-022-02043-6
Chicago-Zitierstil (17. Ausg.)Blasi, Miriam, et al. "Major Clinical Benefit from Adjuvant Chemotherapy for Stage II-III Non-small Cell Lung Cancer Patients Aged 75 years or Older: A Propensity Score-matched Analysis." BMC Pulmonary Medicine 22 (2022). https://doi.org/10.1186/s12890-022-02043-6.
MLA-Zitierstil (9. Ausg.)Blasi, Miriam, et al. "Major Clinical Benefit from Adjuvant Chemotherapy for Stage II-III Non-small Cell Lung Cancer Patients Aged 75 years or Older: A Propensity Score-matched Analysis." BMC Pulmonary Medicine, vol. 22, 2022, https://doi.org/10.1186/s12890-022-02043-6.